Appointments
Phase I clinical trial specialist Cedra Corp division has appointed Anthony Busa as its new permanent chief executive, replacing acting chief...
Swiss clinical stage biopharmaceutical company Telormedix has appointed Phillipe Lutz chief financial officer.
He joins the company from...
Euro RSCG Life Medicom has four new starters to handle new international and domestic business.
They are Antonia Ford (pictured left...
Patrick Vallance has been appointed as senior vice president, medicines discovery and development at GlaxoSmithKline, and as a member of the...
Synexus has appointed Dr Helena Sigal as country manager for Germany and Radoslaw Janiak as country manager for Poland.
Helena was...
Dutch human gene therapy company Amsterdam Molecular Therapeutics has appointed Professor Sander van Deventer to its supervisory board.
One...
The European Medicines Agency has appointed Alexis Nolte to head up its Quality of Medicines Sector.
He was previously principal scientific...
Patheon has appointed Dr Mark Kontny president of global pharmaceutical development services and chief scientific officer.
He joins the...
Virgo Health has expanded its medical education offering, appointing Katherine Mantell and Adam Pittard.
Katherine joins the agency as...
Laurence Debroux, chief strategic officer at Sanofi-Aventis, is to leave the company at the end of June.
The company said she was leaving “...